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The Government’s response to COVID-19: how to further realise the right to health
Providing expertise on international human rights law and public health, the contributors 
answer question 1 that the Joint Committee asked:
Question 1: What steps need to be taken to ensure that measures taken by the 
Government to address the COVID-19 pandemic are human rights compliant?
Summary of our recommendations
We recommend that the UK comply with its international obligations to realise the right to 
health, including by:
 Taking immediate steps to avert future high mortality and a disproportionate burden 
on marginalized and vulnerable groups (i.e. older persons, BAME and poor 
communities).
 Enhancing its pandemic preparedness strategy, based on evidence from public 
health experts and guidance from the WHO, and through a participatory process, in 
order to prevent or better manage a second wave, including for marginalized groups;
 Ensuring an adequate supply of PPE for health workers and care home workers, 
including cleaners, to prevent or better manage a second wave;
 Enhancing its capacity to test suspected cases and trace their contacts to ensure 
public surveillance and prevent future waves;
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2 Managing localised lockdowns in a timely and transparent fashion to prevent or 
better manage a second wave;
 Restoring as much as possible access to essential health services for vulnerable 
non-COVID patients, including with the creation of COVID-free hubs; 
 Supporting the development and distribution of a vaccine in compliance with 
standards of the right to health, including the WHO criteria for COVID-19 vaccine 
prioritization;
 Providing human and material resources to the NHS and social care system to cope 
with the long-term effects of the disease, with particular attention to vulnerable 
groups.
 Fostering international cooperation by sharing data on COVID-19, supporting the UN 
Comprehensive Response to COVID-19, and providing assistance to low- and 
middle-income countries on the DAC list;
 A public inquiry into the UK’s COVID-19 response should be framed by the full range 
of the UK’s international human rights obligations including the right to health, and 
led by an independent body of experts.
3I. The UK’s obligations towards the right to health in the COVID-19 pandemic
1. The United Kingdom (“UK”) has legally binding obligations towards the right to the 
enjoyment of the highest attainable standard of physical and mental health (“right to 
health”), deriving from its ratification of international human rights treaties including the 
International Covenant on Economic, Social and Cultural Rights 1966 (“ICESCR”) and 
the European Social Charter 1961.2
2. The United Nations (UN), the World Health Organization (WHO) and the UN Special 
Rapporteur on the right to health have emphasised that the right to health should be at 
the forefront of state responses to COVID-19 (UN, 2020; WHO, 2020a; Puras et al., 
2020).
3. ICESCR recognises States parties must take steps for the ‘prevention, treatment and 
control of epidemic, endemic, occupational and other diseases’ (ICESCR, Article 
12(2)(c); see also European Social Charter, Article 11(1), (3)). In this context, in realising 
the right to health, States must guarantee cross-cutting human rights principles of: 
equality and non-discrimination, participation, transparency and accountability. 
4. In General Comment 14, the Committee on Economic Social and Cultural Rights 
(“CESCR”) highlighted obligations that States are required to fulfil to realise the right to 
health, including: 
 To adopt, implement and regularly review a public health strategy based on 
epidemiological evidence, participation and transparency, in order to address the 
health concerns of the whole population, particularly vulnerable groups; 
 To realise the social determinants of health; 
 To realise available, accessible, acceptable and good quality health care;
 To provide access to health information;
 To provide access to essential drugs as well as immunisation against major 
infectious diseases (CESCR, 2000).
5. These obligations must be realised at the domestic level and the transboundary level, 
through international cooperation (ICESCR, Article 2(1)).
6. Additionally, the UK is a party to the International Health Regulations (WHO, 2005) which 
aim to prevent the spread of infectious diseases, with due attention to the protection of 
human rights.
7. Reflecting on the UK’s response during and since the first wave, as well as the UK’s 
international obligations to realise the right to health, this submission highlights some of 
the steps that the UK need to take in order to ensure that the measures adopted by its 
Government to address the COVID-19 pandemic are compliant with the right to health.
2 The UK has also ratified the following treaties, which recognise the right to health: the UN 
International Covenant on the Elimination of All Forms of Racial Discrimination 1965; the UN 
Convention on the Prevention of All Forms of Discrimination Against Women 1979; the UN 
Convention on the Rights of the Child 1989; the UN Convention on the Rights of Persons with 
Disabilities 2006.
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5II. Specific areas of concern in relation to COVID-19 and recommendations
A. Minimising preventable deaths, and addressing the disproportionate risk of 
infection and death for marginalized and vulnerable groups 
8. The fact that the UK has the highest number of deaths from COVID-19 and second 
highest excess death rate in Europe suggests that many deaths in the UK could have 
been prevented had the Government followed WHO guidelines in the early stages of the 
outbreak, learned from international experience, and acted upon earlier pandemic 
preparedness recommendations of UK bodies. 
9. Research suggests that people from low socio-economic background are at higher risk 
of mortality, which cannot be explained by other risk factors such as underlying health 
conditions (Williamson et al, 2020). Incidence and mortality are also higher in Black, 
Asian and minority ethnic (BAME) communities, as well as in older people, especially 
those living in care homes (PHE, 2020a; PHE, 2020b). 
10. Recommendation: The UK must protect everyone’s right to health, on the basis of 
equality and non-discrimination (ICESCR, Articles 12(1) and 2(2); European Social 
Charter, Article 11), including through targeted measures where required (CESCR, 
2020). We recommend that the UK take immediate steps to avert future high mortality 
and a disproportionate burden on marginalized and vulnerable groups. This should be 
done through the adoption and implementation of appropriate public health strategies, 
based on participatory processes, and which address the factors and social determinants 
that bear upon disparities. 
B. Enhancing pandemic preparedness: learning lessons for the future
11. Despite the risks of an influenza-type pandemic identified by the National Risk Register 
for Civil Emergencies (Cabinet Office, 2015), the limitations of the UK’s preparedness 
revealed by Exercise Cygnus (Public Health England, 2017) and the  WHO Joint 
External Evaluation mission (WHO, 2019), findings from these reviews (including on PPE 
shortages, surge capacity preparedness, lab testing services and entry procedures for 
international travellers) were reportedly not communicated to key stakeholders or 
adequately acted on.
  
12. In the absence of a vaccine, the likelihood of a second wave is high. In an open letter, 
leaders of the medical, nursing and public health professions have recently highlighted 
that the UK is not adequately prepared for this; as it has failed to procure sufficient PPE, 
to step up national efforts to track and trace effectively, and to increase scrutiny in care 
homes (Adebowale et al, 2020). 
13. Recommendation:  The UK must prevent epidemic and endemic diseases (ICESCR, 
Article 12(2)(c)); and must adopt, implement and regularly review a public health strategy 
based on epidemiological evidence, participation and transparency, in order to address 
the health concerns of the whole population, particularly vulnerable groups (CESCR, 
62000). We recommend that the UK conduct a public inquiry to learn lessons from its 
failures to comply with this obligation during the first wave. We also recommend that the 
UK enhance its pandemic preparedness strategy, based on evidence from public health 
experts and guidance from the WHO, and through a participatory process, in order to 
prevent or better manage a second wave and thereby, further realise the right to health 
for all.
C. Ensuring adequate supply of essential medical goods
14. From March to late April, during the peak of the pandemic, several testimonies showed a 
lack of PPE for healthcare workers. In May, the government announced that over 300 
health workers and social workers had died of COVID-19 since March 2020. Care homes 
also lacked the necessary equipment because suppliers prioritised the NHS, whilst PPE 
guidance for care home workers deviated from WHO’s recommended standards in 
several respects (Lewis, 2020). 
15. Recommendation:  The UK must protect everyone’s right to health (ICESCR, Article 
12(1); European Social Charter, Article 11), including health workers and care home 
workers (CESCR, 2020; European Committee of Social Rights, 2020). We recommend 
that the UK conduct a public inquiry to learn lessons from its failures to comply with this 
obligation during the first wave; and that it ensure an adequate supply of PPE for health 
workers and care home workers (including cleaners) to prevent or better manage a 
second wave and thereby, further realise the right to health.
D. Testing, contact tracing and surveillance
16. Testing and contact tracing are a mainstay of infectious disease control (Sekalala and 
Harrington, 2020). Despite interim guidance from WHO issued on 7th March (WHO, 
2020b) to test all suspected cases and trace contacts, as well as positive experiences of 
widespread testing from other jurisdictions such as Germany, Singapore and South 
Korea, the UK government halted community testing on 12th March. Continuing testing 
could have saved lives.
17. Further, testing was also not available in care homes, and until mid-April, there was no 
requirement for persons discharged from hospitals into care homes to have a COVID-19 
test.
18. Testing shortcomings continued during the lockdown. Despite limited capacity, Public 
Health England restricted the conduct of tests to its own laboratories and ignored help 
from universities. Testing capacity scaled up slowly and did not allow NHS workers and 
social care workers to be tested regularly, diminishing the human capacity in the health 
sector due to self-isolation amongst its workforce. The Test and Trace service was only 
launched on 28 May, after the first eases on the lockdown were implemented.
19. There have also been significant shortcomings in terms of communicating second pillar 
testing data with local public health authorities and primary and secondary care (UK 
Statistics Authority, 2020). 
720. Recommendation: The right to health requires the prevention of epidemic and endemic 
diseases (ICESCR, Article 12; CESCR, 2000). The WHO evidences that this is best 
achieved through public health surveillance, by testing suspected cases and tracing their 
contacts (WHO, 2020b). We recommend that the UK conduct a public inquiry to learn 
lessons from its failures to comply with this obligation during the first wave; and that it 
guarantees robust testing and contact tracing capacity and surveillance in order to 
prevent or better manage a second wave and thereby, further realise the right to health 
(European Committee Social Rights, 2020).
E. Adopting lockdown measures 
21. The Government’s strategy prior to lockdown on 23 March would have costed an 
estimated 260,000 lives and overwhelmed the NHS (Ferguson et al, 2020). It ignored 
WHO interim advice issued on 7 March to consider cancelling mass gatherings and 
closing schools, public transportation and workplaces (WHO, 2020b). The week 
preceding the lockdown, while the official advice was to stay at home, employers had the 
power to decide who should travel to the office, social venues remained open, and 
sporting events were not forced to close. Strong compulsory measures were only 
implemented on 25 and 26 March by the Coronavirus Act 2020 and the Health Protection 
(Coronavirus, Restrictions) Regulations 2020. The UK was also very late in coming with 
a plan for quarantining people who were coming from countries in which COVID-19 was 
already endemic.
22. The UK only implemented a national lockdown on 23 March. By that time, lockdowns 
were already in force for several weeks in other European countries. Former SAGE 
member Neil Ferguson, and Chief Medical Officer Chris Whitty, have subsequently 
suggested that locking down one week earlier would have halved the death toll (Stuart, 
Sample, 2020). 
23. Furthermore, the only localised lockdown to date (Leicester) highlights a lack of 
transparency from the Government for not providing data in a timely fashion and not 
communicating the threshold for localised lockdowns. 
24. Recommendation: The right to health requires the UK to adopt, implement and 
regularly review a public health strategy based on epidemiological evidence, participation 
and transparency (CESCR, 2000). We recommend that the UK conduct a public inquiry 
to learn lessons from its failures to comply with this obligation during the first wave; and 
that it adopt lockdown measures (at a local or national level), if required, in a timely, 
participatory and transparent fashion, providing support to avoid undermining social and 
economic rights, to prevent or better manage a second wave and thereby, further realise 
the right to health. 
8F. Managing the disrupted access to other health services due to COVID-19
25. Access to both general and acute care services has been severely affected since the 
beginning of the pandemic, with a significant impact on individuals with underlying health 
conditions. Whilst recognising the exigencies of the COVID-19 outbreak, we are 
particularly concerned that cancer screening programmes in the UK were paused from 
mid-March to mid-June. New estimates predict a 20% increase in cancer deaths in the 
next 12 months among new diagnoses, as well as additional deaths due to late 
diagnoses and delayed treatments (Wise, 2020). We are also concerned that all elective 
surgeries were suspended on 17 March, carrying risks of significant harm to patients.
26. Recommendation: The UK must protect everyone’s right to health, ensure access to 
health care facilities and services on a non-discriminatory basis, and guard against 
retrogression in service provision (ICESCR, Article 12; CESCR, 2000). We recommend 
that the UK immediately implement additional measures to minimise the disruption of 
essential health services for non-COVID patients, including with the creation of COVID-
free hubs to treat these patients.
G. Planning for vaccine development and distribution
27. In the event of a successful COVID-19 vaccine, decisions about distribution, within the 
UK and globally, must be compliant with relevant right to health obligations. Therefore, 
the UK should: make it available in sufficient quantity; distribute it in priority to individuals 
who are more likely to contract COVID-19 and those whose health is at higher risk of 
being seriously compromised by COVID-19. The UK should also ensure that a COVID-
19 vaccine is: distributed within safe physical reach for all; affordable for all; respectful of 
key medical ethics concepts such as patients’ protection, consent and confidentiality; 
safe and of a quality acceptable by clinical standards (CESCR, 2000). Finally, a COVID-
19 vaccine should be distributed globally on an equitable basis and for free, through use 
of flexibilities in intellectual property regimes (CESCR, 2020).  
28. Recommendation: It is fundamental the UK prepares immediately to the deployment of 
a COVID-19 vaccine in order to facilitate a speedy, efficient and right to health-compliant 
process. Therefore, we welcome the independent report from the UK Joint Committee on 
Vaccination and Immunisation (JCVI) on the groups that should be prioritised for 
vaccination (18 June 2020) and remind the UK of the WHO criteria for COVID-19 
vaccine prioritization (WHO, 2020c). 
H. Coping with the long-term health effects of COVID-19
29. While uncertainty remains on the long-term effects of COVID-19, preliminary 
observations suggest damage to the lungs, heart, brain, kidneys, gastrointestinal tract 
and the nervous system; as well as effects on mental health. We welcome the £8.4 
million research into the long-term effects of the disease, and the launch of the COVID-
19 rehab service.
930. Recommendation: The UK must devote maximum available resources to realise the 
right to health for all (ICESCR, Articles 2(1) and 12). We recommend that the UK provide 
human and material resources to the NHS and social care system to cope with the long-
term effects of the disease, with particular attention to vulnerable groups.
I. Complying with transboundary obligations under the right to health
31. The UN Secretary-General, the WHO and the CESCR have called for international 
cooperation and solidary in the response to COVID-19 (WHO, 2020a; CESCR, 2020). 
The CESCR has clarified that this should include: “sharing of research, medical 
equipment and supplies, and best practices in combating the virus; coordinated action to 
reduce the economic and social impacts of the crisis; and joint endeavours by all States 
to ensure an effective, equitable economic recovery. The needs of vulnerable and 
disadvantaged groups as well as fragile countries, including least developed countries, 
countries in conflict and post-conflict situations, should be at the centre of such 
international endeavours” (CESCR, 2020). In this statement, the CESCR has also 
emphasised the importance of sharing the best scientific knowledge to expedite the 
discovery of effective treatments and vaccines, and the promotion of flexibilities in 
intellectual property regimes to allow universal access to the benefits of scientific 
advancements relating to COVID-19 such as diagnostics, medicines and vaccines 
(CESCR, 2020; also see Harrington and Sekalala, 2020; and Bueno de Mesquita and 
Mason Meier, 2020).
32. Recommendation: These obligations are particularly important considering the leading 
role of the UK in the development of a COVID-19 vaccine, as the vaccine researched by 
the University of Oxford/AstraZeneca is at the most advanced stage of clinical trials 
worldwide. Therefore, the UK should ensure that its actions are guided by the promotion 
and protection of the right to health worldwide, in line with its obligations under the 
ICESCR as discussed above. The UK should also fully support the UN Comprehensive 
Response to COVID-19, and provide assistance to low- and middle-income countries on 
the DAC list.
III. Accountability and inquiry
33. Accountability is a central preoccupation of human rights law and will be central to 
assess responses as well as improve health systems and related services in the face of 
COVID-19. Accountability, which requires monitoring, independent review, remedies and 
redress, can only be achieved where there is transparency surrounding decision making 
(Bueno de Mesquita, Evans and Fuchs, 2018). Assessing the UK’s compliance with right 
to health standards will entail reviewing the adequacy of its health system, by examining 
its attempts to protect human dignity, to not discriminate, and to integrate fast-moving 
public health expertise (Lougarre, 2015) in the face of COVID-19.   
34. Recommendation: We recommend that a future public inquiry into COVID-19 must be 
framed with reference to the full range of international human right obligations of the UK, 
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